Suro Senen

The GLP-1 Paradox: Biopharma’s R&D Productivity Rebound Masks Deep Structural Fragility

• Chemotherapy and Targeted Therapy

The GLP-1 Paradox: Biopharma’s R&D Productivity Rebound Masks Deep Structural Fragility

Suro Senen May 30, 2026 0

After a prolonged period of "post-pandemic hibernation"—characterized by uneven growth and dwindling R&D returns—the global biopharmaceutical sector...

Read More Read more about The GLP-1 Paradox: Biopharma’s R&D Productivity Rebound Masks Deep Structural Fragility

Navigating Fiscal Uncertainty: North Carolina’s Medicaid Overhaul in the Wake of Federal Reconciliation

• Breast Cancer Legislation and Policy

Navigating Fiscal Uncertainty: North Carolina’s Medicaid Overhaul in the Wake of Federal Reconciliation

Suro Senen May 29, 2026 0

On April 30, 2026, North Carolina Governor Josh Stein signed into law a critical piece of legislation—House...

Read More Read more about Navigating Fiscal Uncertainty: North Carolina’s Medicaid Overhaul in the Wake of Federal Reconciliation

Strengthening the Frontline of Oncology: Breast Cancer Canada and CSSO Launch Landmark $200,000 Research Award

• Patient Advocacy and Support

Strengthening the Frontline of Oncology: Breast Cancer Canada and CSSO Launch Landmark $200,000 Research Award

Suro Senen May 29, 2026 0

The landscape of Canadian breast cancer treatment is witnessing a pivotal shift toward homegrown innovation and data-driven...

Read More Read more about Strengthening the Frontline of Oncology: Breast Cancer Canada and CSSO Launch Landmark $200,000 Research Award

Bridging the Gap: Bionews Unveils “The Rare Journey,” a New Frontier in Patient-Centered Storytelling

• Radiation Oncology

Bridging the Gap: Bionews Unveils “The Rare Journey,” a New Frontier in Patient-Centered Storytelling

Suro Senen May 29, 2026 0

PENSACOLA, Florida — August 19, 2024 — In the landscape of chronic health, the experience of living...

Read More Read more about Bridging the Gap: Bionews Unveils “The Rare Journey,” a New Frontier in Patient-Centered Storytelling

The Architecture of Balance: Mastering Parsvottanasana (Pyramid Pose)

• Integrative Oncology and Holistic Care

The Architecture of Balance: Mastering Parsvottanasana (Pyramid Pose)

Suro Senen May 29, 2026 0

Published May 28, 2026 | Originally appeared in the November 2008 issue of Yoga Journal In the...

Read More Read more about The Architecture of Balance: Mastering Parsvottanasana (Pyramid Pose)

A New Frontier in Cardiology: Eli Lilly’s Base-Editing Breakthrough Promises One-Time Cholesterol Treatment

• Treatment Innovations

A New Frontier in Cardiology: Eli Lilly’s Base-Editing Breakthrough Promises One-Time Cholesterol Treatment

Suro Senen May 29, 2026 0

By Jonathan Gardner Published May 26, 2026 In a milestone that could redefine the standard of care...

Read More Read more about A New Frontier in Cardiology: Eli Lilly’s Base-Editing Breakthrough Promises One-Time Cholesterol Treatment

Decades-Old Protein, EPO, Unmasked as Master Regulator of Cancer Immunity, Offering New Hope for "Cold" Tumors

• Medical Research and Clinical Trials

Decades-Old Protein, EPO, Unmasked as Master Regulator of Cancer Immunity, Offering New Hope for "Cold" Tumors

Suro Senen May 28, 2026 0

STANFORD, CA – April 24, 2024 – A scientific revelation, published today in the prestigious journal Science,...

Read More Read more about Decades-Old Protein, EPO, Unmasked as Master Regulator of Cancer Immunity, Offering New Hope for "Cold" Tumors

Breakthrough Trial Launched for IgA Nephropathy: Jade Biosciences Doses First Participant in JUNIPER Study of JADE101

• Medical Research and Clinical Trials

Breakthrough Trial Launched for IgA Nephropathy: Jade Biosciences Doses First Participant in JUNIPER Study of JADE101

Suro Senen May 28, 2026 0

A significant stride has been made in the fight against IgA nephropathy (IgAN), a chronic autoimmune kidney...

Read More Read more about Breakthrough Trial Launched for IgA Nephropathy: Jade Biosciences Doses First Participant in JUNIPER Study of JADE101

Breakthrough in Personalized Pediatric Cancer Treatment: Chicken Eggs and Protein Analysis Offer New Hope

• Medical Research and Clinical Trials

Breakthrough in Personalized Pediatric Cancer Treatment: Chicken Eggs and Protein Analysis Offer New Hope

Suro Senen May 27, 2026 0

Vancouver, BC – In a monumental leap forward for pediatric oncology, a pioneering pan-Canadian research team has...

Read More Read more about Breakthrough in Personalized Pediatric Cancer Treatment: Chicken Eggs and Protein Analysis Offer New Hope

AI Breakthrough: UCLA Study Reveals Artificial Intelligence Could Revolutionize Early Detection of Interval Breast Cancers

• Medical Research and Clinical Trials

AI Breakthrough: UCLA Study Reveals Artificial Intelligence Could Revolutionize Early Detection of Interval Breast Cancers

Suro Senen May 27, 2026 0

Los Angeles, CA – A groundbreaking study spearheaded by investigators at the UCLA Health Jonsson Comprehensive Cancer...

Read More Read more about AI Breakthrough: UCLA Study Reveals Artificial Intelligence Could Revolutionize Early Detection of Interval Breast Cancers